Department of Transplantation, Guy's Hospital, Guy's and St Thomas' NHS Foundation Trust, Great Maze Pond, London, SE1 9RT, UK.
School of Population Health and Environmental Studies, King's College London, London, UK.
J Nephrol. 2020 Apr;33(2):371-381. doi: 10.1007/s40620-019-00654-7. Epub 2019 Oct 3.
We assessed the effect of recipient body mass index (BMI) on the outcomes of renal transplantation and the management of obese patients with end-stage renal disease across the UK.
We analyzed data of 25539 adult renal transplants (2007-2016) from the UK Transplant Registry. Patients were divided in BMI groups [underweight: < 18.5, normal: 18.5-24.9 (reference group), overweight: 25-29.9, class I obese: 30-34.9, class II/III obese: ≥ 35]. We also conducted a national survey of all UK renal transplant centers on the influence of BMI on decisions regarding management of renal transplant candidates.
BMI ≥ 25 was an independent risk factor for delayed graft function and primary non-function (p ≤ 0.001). Underweight (p = 0.001), class I obese (p = 0.017) and class II/III obese recipients (p < 0.001) had poorer graft survival, however, 5- and 10-year graft survival rates were good. Patient survival was shorter for underweight recipients (p < 0.001) and longer for overweight (p = 0.028) and class I obese recipients (p = 0.013). The national survey revealed significant variability among transplant centers in BMI threshold for listing patients on transplant waiting list and limited support with conservative or surgical procedures for weight control.
Obesity alone should not be a barrier for renal transplantation. A national strategy is required to give all patients equal chances in transplantation.
本研究旨在评估受体体重指数(BMI)对英国肾脏移植结局的影响,以及肥胖终末期肾病患者的管理方法。
我们分析了英国移植登记处 2007 年至 2016 年间 25539 例成人肾脏移植的数据。患者被分为 BMI 组[体重不足:<18.5;正常体重:18.5-24.9(参考组);超重:25-29.9;I 度肥胖:30-34.9;II/III 度肥胖:≥35]。我们还对英国所有肾脏移植中心进行了一项关于 BMI 对肾脏移植候选者管理决策影响的全国性调查。
BMI≥25 是延迟移植物功能和原发性无功能的独立危险因素(p≤0.001)。体重不足(p=0.001)、I 度肥胖(p=0.017)和 II/III 度肥胖的受体移植物存活率较差,但 5 年和 10 年移植物存活率良好。体重不足的受体患者生存率较短(p<0.001),超重(p=0.028)和 I 度肥胖(p=0.013)的受体患者生存率较长。全国性调查显示,移植中心在将患者列入移植等待名单的 BMI 阈值和对体重控制的保守或手术治疗的支持方面存在显著差异。
肥胖不应成为肾脏移植的障碍。需要制定国家策略,为所有患者提供平等的移植机会。